Zin War Myint

机构：University of Kentucky, Markey Cancer Center · ORCID：0000-0002-3479-4203

发表论文 162 篇 · 总被引 1489 次 · h-index 17

代表论文

Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study (2024 · European Urology Oncology · 被引 23)
Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study (2025 · Cancer Immunology Immunotherapy · 被引 10)
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study (2025 · Cancer Immunology Immunotherapy · 被引 10)
Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON ‐2 Retrospective Experience (2025 · Cancer Medicine · 被引 9)
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study (2026 · Prostate Cancer and Prostatic Diseases · 被引 8)
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) (2025 · Cancer Immunology Immunotherapy · 被引 5)